Get started
Author

Stefania Russo

Observed names: Russo, Stefania, S Russo, S. Russo, S.M. Russo, Stefania\ Russo
Observed institutions: University of Rome Tor Vergata, University of Udine, University of Milan, Aarhus University Hospital, Stazione Zoologica Anton Dohrn, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, CoNISMa, National Center for Oncological Hadrontherapy, Federico II University Hospital, University Hospitals Seidman Cancer Center, Ospedale Santa Maria della Misericordia di Udine, Centro di Riferimento Oncologico, Centro Diagnostico Italiano, National Research Council, Istituto di Studi sul Mediterraneo (CNR - ISMed), Azienda sanitaria universitaria Friuli Centrale, University of Turin, European Institute of Oncology, University of Naples Federico II, University of Palermo
ORCID: 0000-0003-0114-8042
Observed ORCID: 0000-0003-0114-8042
OpenAlex ID: A5080029458
Spatial predictors of immunotherapy response in triple-negative breast cancer
2023 · Xiao Qian Wang, Esther Danenberg, et al. · Nature · 362
PDF
Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
2014 · Marta Bonotto, Lorenzo Gerratana, et al. · The Oncologist · 295
PDF
Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications
2005 · F. Puglisi, A. Follador, et al. · Annals of Oncology · 156
Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study
2020 · Luca Gianni, Chiun-Sheng Huang, et al. · Cancer Research · 133
Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems
2016 · Silvia Molinelli, Giuseppe Magro, et al. · Radiotherapy and Oncology · 93
Characterization of a commercial scintillation detector for 2-D dosimetry in scanned proton and carbon ion beams
2017 · S. Russo, A. Mirandola, et al. · Physica Medica · 89
Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy
2020 · Alberto Iannalfi, Emma D’Ippolito, et al. · Neuro-Oncology · 78
PDF
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
2022 · Lucia Del Mastro, Francesca Poggio, et al. · The Lancet Oncology · 54
Dosimetric characterization of carbon fiber stabilization devices for post-operative particle therapy
2017 · E. Mastella, S. Molinelli, et al. · Physica Medica · 51
Iron Deficiency and Intestinal Malabsorption in HIV Disease
1996 · Annunziata Castaldo, Luigi Tarallo, et al. · Journal of Pediatric Gastroenterology and Nutrition · 50
Commissioning of the 4-D treatment delivery system for organ motion management in synchrotron-based scanning ion beams
2016 · Mario Ciocca, Alfredo Mirandola, et al. · Physica Medica · 43
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
2008 · F. Puglisi, G.G. Cardellino, et al. · Annals of Oncology · 43
PDF
Design and commissioning of the non‐dedicated scanning proton beamline for ocular treatment at the synchrotron‐based CNAO facility
2019 · Mario Ciocca, Giuseppe Magro, et al. · Medical Physics · 40
Factors affecting patient's perception of anticancer treatments side-effects: an observational study
2013 · Stefania Russo, Marika Cinausero, et al. · Expert Opinion on Drug Safety · 39
Signature of B‐CLL with different prognosis by Shrunken centroids of surface antigen expression profiling
2004 · Antonella Zucchetto, Paolo Sonego, et al. · Journal of Cellular Physiology · 33
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer
2021 · Andrew Wardley, Javier Cortes, et al. · Breast Cancer Research and Treatment · 32
PDF
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer
2020 · Lorenzo Gerratana, Debora Basile, et al. · Frontiers in Oncology · 29
PDF
LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study
2023 · L. Gianni, C. Huang, et al. · Annals of Oncology · 28
PDF
RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes
2019 · Silvia Molinelli, Maria Bonora, et al. · Radiotherapy and Oncology · 28
Hodgkin and Reed–Sternberg cells express functional c‐kit receptors and interact with primary fibroblasts from Hodgkin's disease‐involved lymph nodes through soluble and membrane‐bound stem cell factor
2002 · Donatella Aldinucci, Dalisa Poletto, et al. · British Journal of Haematology · 27
PDF
Dosimetric accuracy of a treatment planning system for actively scanned proton beams and small target volumes: Monte Carlo and experimental validation
2015 · G Magro, S Molinelli, et al. · Physics in Medicine and Biology · 25
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision
2022 · Alessandro Vai, Silvia Molinelli, et al. · Cancers · 24
PDF
Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes
2019 · Kyungdon Choi, Silvia Molinelli, et al. · Cancers · 24
PDF
Risk of carotid blowout after reirradiation with particle therapy
2017 · Jon Espen Dale, Silvia Molinelli, et al. · Advances in Radiation Oncology · 21
PDF
Anthracyclines and taxanes induce the upregulation of thymidine phosphorylase in breast cancer cells
2007 · Fabio Puglisi, Claudia Andreetta, et al. · Anti-Cancer Drugs · 21
Works count: 170
Citation count: 2,388
H-index: 23
I10-index: 52
Year
Topic
Type